S
ServareGMP
Profile set up by Edverise AISet Up By Edverise AI
Edverise AI built this profile by analyzing thousands of data points across the web. If you own this business, become an Edverise partner to manage and update your profile.
Overview
$250,000+
Min Project Size
10 - 49
Employees
2020
Year Founded
ABOUT SERVAREGMP
Bioligics for vulnerable populations
We are a non-profit biotechnology organization established to create biological treatments for low- and middle-income countries (LMICs) and refugee camps for displaced individuals.
LANGUAGES SPOKEN
English
HIGHLIGHTS
$250,000+
Min Project Size
10 - 49
Employees
2020
Year Founded
Services
Focus
Industries
Clients
Services Provided
60% Healthcare Services
40% Business Consulting Services
About the Team
OUR STORY
ServareGMP is helmed by a distinguished leadership team and an expert scientific board. Under the guidance of Executive Director Gary Pierce and Chief Scientific Officer Leigh Pierce, both founders of PacificGMP, the company benefits from extensive experience in pharmaceutical excellence. The board includes prominent figures such as Larry Zeitlin and Kevin Whaley, founders of Mapp Biopharmaceuticals, alongside Tom Ransohoff, Ho Cho, and Oren Beske, bringing diverse expertise. Chief Financial Officer Gregory P. Hanson has led financial strategy since mid-2024. The scientific advisory board features renowned professionals like Dr. Joan Robbins, Dr. Teresa O'Dea, Bernard Parker, and others, who contribute deep knowledge spanning translational medicine, pediatrics, commercialization, mental health, and clinical pharmacology. This robust team reflects ServareGMP's commitment to advancing medical
Projects & Clients
Project Size & Rate
Minimum Project Size
$250,000+